Your browser doesn't support javascript.
loading
Proteome-scale discovery of protein degradation and stabilization effectors.
Poirson, Juline; Cho, Hanna; Dhillon, Akashdeep; Haider, Shahan; Imrit, Ahmad Zoheyr; Lam, Mandy Hiu Yi; Alerasool, Nader; Lacoste, Jessica; Mizan, Lamisa; Wong, Cassandra; Gingras, Anne-Claude; Schramek, Daniel; Taipale, Mikko.
Afiliação
  • Poirson J; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
  • Cho H; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
  • Dhillon A; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
  • Haider S; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Imrit AZ; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Lam MHY; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Alerasool N; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
  • Lacoste J; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Mizan L; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
  • Wong C; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
  • Gingras AC; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Schramek D; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
  • Taipale M; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Nature ; 628(8009): 878-886, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38509365
ABSTRACT
Targeted protein degradation and stabilization are promising therapeutic modalities because of their potency, versatility and their potential to expand the druggable target space1,2. However, only a few of the hundreds of E3 ligases and deubiquitinases in the human proteome have been harnessed for this purpose, which substantially limits the potential of the approach. Moreover, there may be other protein classes that could be exploited for protein stabilization or degradation3-5, but there are currently no methods that can identify such effector proteins in a scalable and unbiased manner. Here we established a synthetic proteome-scale platform to functionally identify human proteins that can promote the degradation or stabilization of a target protein in a proximity-dependent manner. Our results reveal that the human proteome contains a large cache of effectors of protein stability. The approach further enabled us to comprehensively compare the activities of human E3 ligases and deubiquitinases, identify and characterize non-canonical protein degraders and stabilizers and establish that effectors have vastly different activities against diverse targets. Notably, the top degraders were more potent against multiple therapeutically relevant targets than the currently used E3 ligases cereblon and VHL. Our study provides a functional catalogue of stability effectors for targeted protein degradation and stabilization and highlights the potential of induced proximity screens for the discovery of new proximity-dependent protein modulators.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteoma / Proteômica / Ubiquitina-Proteína Ligases / Estabilidade Proteica / Proteólise / Enzimas Desubiquitinantes Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteoma / Proteômica / Ubiquitina-Proteína Ligases / Estabilidade Proteica / Proteólise / Enzimas Desubiquitinantes Limite: Humans Idioma: En Revista: Nature Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá